MedWatch

Gubra enters million-dollar agreement with big pharma

The Danish biotech company Gubra has announced a collaboration with a major German drug group for the development of novel peptide compounds. The deal has a potential value of EUR 250 million or approximately DKK 2 billion.

Photo: Colourbox

Log in to read our articles

Welcome to MedWatch. A part of our content is exclusive and reserved for our users.

Try us for 14 days

Try a trial subscription for access to our quality journalism

Frontpage right now

Græske politikere skal undersøges i Novartis-sag

Det græske parlament har besluttet at nedsætte et særligt udvalg, der skal undersøge politikernes rolle i den påståede Novartis-skandale. Novartis’ græske direktør betvivler, at den overhovedet har fundet sted.

Related articles